Wan‐Ting Ho

1.3k total citations
33 papers, 856 citations indexed

About

Wan‐Ting Ho is a scholar working on Molecular Biology, Hematology and Genetics. According to data from OpenAlex, Wan‐Ting Ho has authored 33 papers receiving a total of 856 indexed citations (citations by other indexed papers that have themselves been cited), including 18 papers in Molecular Biology, 13 papers in Hematology and 12 papers in Genetics. Recurrent topics in Wan‐Ting Ho's work include Myeloproliferative Neoplasms: Diagnosis and Treatment (12 papers), Chronic Myeloid Leukemia Treatments (11 papers) and Eosinophilic Disorders and Syndromes (8 papers). Wan‐Ting Ho is often cited by papers focused on Myeloproliferative Neoplasms: Diagnosis and Treatment (12 papers), Chronic Myeloid Leukemia Treatments (11 papers) and Eosinophilic Disorders and Syndromes (8 papers). Wan‐Ting Ho collaborates with scholars based in United States, China and Taiwan. Wan‐Ting Ho's co-authors include John H. Exton, Xie Zhi, Zhizhuang Joe Zhao, Seung‐Kiel Park, Joseph Provost, Xueqi Fu, Wanke Zhao, Mingjiang Xu, Shu Xing and Qingshan Li and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Journal of Biological Chemistry and Blood.

In The Last Decade

Wan‐Ting Ho

33 papers receiving 843 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Wan‐Ting Ho United States 18 524 169 159 144 76 33 856
Lurong Lian United States 17 305 0.6× 211 1.2× 180 1.1× 111 0.8× 112 1.5× 24 753
Valentina Poletto Italy 20 381 0.7× 128 0.8× 59 0.4× 198 1.4× 83 1.1× 35 916
Jared Iacovelli United States 19 713 1.4× 242 1.4× 90 0.6× 169 1.2× 65 0.9× 23 1.3k
Claire Chaussade New Zealand 20 790 1.5× 106 0.6× 262 1.6× 145 1.0× 110 1.4× 26 1.2k
Cecilia Evangelisti Italy 18 466 0.9× 222 1.3× 105 0.7× 96 0.7× 139 1.8× 28 928
Luena Papa United States 11 493 0.9× 135 0.8× 112 0.7× 74 0.5× 66 0.9× 16 744
A. Oda Japan 18 484 0.9× 600 3.6× 245 1.5× 190 1.3× 134 1.8× 32 1.4k
Puneet S. Jolly United States 15 817 1.6× 60 0.4× 296 1.9× 143 1.0× 109 1.4× 30 1.2k
Jean Grisouard Switzerland 16 481 0.9× 155 0.9× 26 0.2× 225 1.6× 161 2.1× 19 857
Carmela Ciccarelli Italy 20 941 1.8× 47 0.3× 120 0.8× 91 0.6× 245 3.2× 29 1.4k

Countries citing papers authored by Wan‐Ting Ho

Since Specialization
Citations

This map shows the geographic impact of Wan‐Ting Ho's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Wan‐Ting Ho with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Wan‐Ting Ho more than expected).

Fields of papers citing papers by Wan‐Ting Ho

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Wan‐Ting Ho. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Wan‐Ting Ho. The network helps show where Wan‐Ting Ho may publish in the future.

Co-authorship network of co-authors of Wan‐Ting Ho

This figure shows the co-authorship network connecting the top 25 collaborators of Wan‐Ting Ho. A scholar is included among the top collaborators of Wan‐Ting Ho based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Wan‐Ting Ho. Wan‐Ting Ho is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Lin, Kun‐Ling, Bin‐Nan Wu, Shu‐Mien Chuang, et al.. (2018). Epigallocatechin-3-gallate alleviates bladder overactivity in a rat model with metabolic syndrome and ovarian hormone deficiency through mitochondria apoptosis pathways. Scientific Reports. 8(1). 5358–5358. 20 indexed citations
2.
Bartenstein, Matthias, Wanke Zhao, Wan‐Ting Ho, et al.. (2017). Efficacy of ALK5 inhibition in myelofibrosis. JCI Insight. 2(7). e90932–e90932. 34 indexed citations
3.
Chen, Yun, Yihang Pan, Wanke Zhao, et al.. (2017). Tyrosine kinase inhibitors targeting FLT3 in the treatment of acute myeloid leukemia. PubMed. 4(6). 48–48. 35 indexed citations
4.
Lin, Kun‐Ling, Shu‐Mien Chuang, Yung‐Chin Lee, et al.. (2017). Elucidating Mechanisms of Bladder Repair after Hyaluronan Instillation in Ketamine-Induced Ulcerative Cystitis in Animal Model. American Journal Of Pathology. 187(9). 1945–1959. 30 indexed citations
5.
Chiou, Shean‐Jaw, et al.. (2016). Arecoline-induced pro-fibrotic proteins in LLC-PK1 cells are dependent on c-Jun N-terminal kinase. Toxicology. 344-346. 53–60. 10 indexed citations
6.
Ho, Wan‐Ting, et al.. (2016). Histone methyltransferase Suv39h1 attenuates high glucose-induced fibronectin and p21WAF1 in mesangial cells. The International Journal of Biochemistry & Cell Biology. 78. 96–105. 18 indexed citations
7.
Zhao, Wanke, et al.. (2014). Generation and Characterization of a JAK2V617F-Containing Erythroleukemia Cell Line. PLoS ONE. 9(7). e99017–e99017. 1 indexed citations
8.
Jin, Xi, Wanke Zhao, Kaiyao Shi, Wan‐Ting Ho, & Zhizhuang Joe Zhao. (2013). Generation of a New Congenic Mouse Strain with Enhanced Chymase Expression in Mast Cells. PLoS ONE. 8(12). e84340–e84340. 6 indexed citations
9.
Chen, Yun, et al.. (2012). Generation and characterization of a highly effective protein substrate for analysis of FLT3 activity. Journal of Hematology & Oncology. 5(1). 39–39. 2 indexed citations
10.
Zhao, Wanming, Jiyun Lee, Shu Xing, et al.. (2011). Relevance of JAK2V617F positivity to hematological diseases - survey of samples from a clinical genetics laboratory. Journal of Hematology & Oncology. 4(1). 4–4. 10 indexed citations
11.
Wang, Shaofeng, et al.. (2010). Identification of a variant form of tyrosine phosphatase LYP. BMC Molecular Biology. 11(1). 78–78. 17 indexed citations
12.
Ma, Junfeng, Fenghua Zeng, Wan‐Ting Ho, et al.. (2008). Characterization and functional studies of a FYVE domain‐containing phosphatase in C. elegans. Journal of Cellular Biochemistry. 104(5). 1843–1852. 5 indexed citations
13.
Li, Zhe, Shu Xing, Shaofeng Wang, Wan‐Ting Ho, & Zhizhuang Joe Zhao. (2007). Characterization of a Highly effective protein substrate for analysis of JAK2V617F Activity. Experimental Hematology. 35(11). 1624–1632. 8 indexed citations
14.
Li, Zhe, Mingjiang Xu, Shu Xing, et al.. (2006). Erlotinib Effectively Inhibits JAK2V617F Activity and Polycythemia Vera Cell Growth. Journal of Biological Chemistry. 282(6). 3428–3432. 100 indexed citations
16.
Zhi, Xie, et al.. (2002). Mechanisms of Regulation of Phospholipase D1 and D2 by the Heterotrimeric G Proteins G13 and Gq. Journal of Biological Chemistry. 277(14). 11979–11986. 30 indexed citations
17.
Zhi, Xie, Wan‐Ting Ho, & John H. Exton. (2001). Requirements and Effects of Palmitoylation of Rat PLD1. Journal of Biological Chemistry. 276(12). 9383–9391. 20 indexed citations
18.
Zhi, Xie, Wan‐Ting Ho, & John H. Exton. (2000). Association of the N- and C-terminal Domains of Phospholipase D. Journal of Biological Chemistry. 275(32). 24962–24969. 47 indexed citations
19.
Ho, Wan‐Ting, et al.. (1999). Phospholipase D Mediates Matrix Metalloproteinase-9 Secretion in Phorbol Ester-stimulated Human Fibrosarcoma Cells. Journal of Biological Chemistry. 274(2). 735–738. 66 indexed citations
20.
Park, Seung‐Kiel, et al.. (1997). Cloning and Characterization of Phospholipase D from Rat Brain. Journal of Biological Chemistry. 272(46). 29263–29271. 124 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026